It's not for me: speed of Covid-19 vaccine race raises safety concerns | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Multimedia
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Sunday
December 10, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Multimedia
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
SUNDAY, DECEMBER 10, 2023
It's not for me: speed of Covid-19 vaccine race raises safety concerns

Coronavirus chronicle

Reuters
06 August, 2020, 09:25 pm
Last modified: 06 August, 2020, 09:28 pm

Related News

  • Bolsonaro home raided, phone seized in Brazil vaccine records probe
  • WHO provides 11 lakh bivalent vaccines to Bangladesh: Minister
  • Incepta Pharma abandons Covid vaccine plan
  • AstraZeneca, Moderna recipients to receive Pfizer vaccine to mix-and-match
  • Children aged 5-11 to get Covid jabs from 11 August

It's not for me: speed of Covid-19 vaccine race raises safety concerns

There are more than 200 Covid-19 vaccine candidates in development globally, including more than 20 in human clinical trials

Reuters
06 August, 2020, 09:25 pm
Last modified: 06 August, 2020, 09:28 pm
File Photo: Small bottles labelled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration/File Photo
File Photo: Small bottles labelled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration/File Photo

The frenetic race to develop a Covid-19 vaccine has intensified safety concerns about an inoculation, prompting governments and drugmakers to raise awareness to ensure their efforts to beat the coronavirus aren't derailed by public distrust.

There are more than 200 Covid-19 vaccine candidates in development globally, including more than 20 in human clinical trials. US President Donald Trump has vowed to have a shot ready before year's end, although they typically take 10 years or longer to develop and test for safety and effectiveness.

In the drive to find a potential Covid-19 vaccine "fast is good for politicians," said Heidi Larson, who leads the Vaccine Confidence Project (VCP), a global surveillance programme on vaccine trust. "But from the public perspective, the general sentiment is: 'too fast can't be safe'", she told Reuters.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Regulators around the world have repeatedly said speed will not compromise safety, as quicker results would stem from conducting in parallel trials that are usually done in sequence.

However, these reassurances have failed to convince many, including in Western countries where scepticism about vaccinations was already growing before the pandemic.

Preliminary results of a survey conducted over the last three months in 19 countries showed that only about 70 percent of British and US respondents would take a Covid-19 vaccine if available, Scott Ratzan, co-leader of 'Business Partners to CONVINCE', told Reuters.

Business Partners to CONVINCE, a US/UK initiative that is partly government funded, conducted the survey jointly with VCP and the results were broadly in line with a Reuters/Ipsos poll of the US public in May.

"We just see this distrust growing against science and government," said Ratzan.

"We need to address legitimate concerns about the rapid pace of development, political over-promises and the risks of vaccination."

The VCP/Business Partners' survey, expected to be published in a few weeks, will also show that Chinese participants were the most trusting of vaccines, while Russians were the least so, Ratzan said.

Drugmakers and governments had hoped the scale of the Covid-19 crisis would allay concerns about vaccines, which they see as crucial to defeating the pandemic and enabling economies to fully recover from its impact.

Vaccine hesitancy - or the reluctance or refusal to be vaccinated - is also known as "anti-vax", a term that is sometimes associated with conspiracy theories when often it simply reflects many people's concerns about side-effects or industry ethics.

In January 2019 the World Health Organisation named vaccine hesitancy as one of the top 10 global health threats for that year.

TAILORED MESSAGES

In Europe, scepticism among the public was high before the pandemic due to a range of factors including negative coverage of pharmaceutical companies as well as false theories including suggested links between childhood immunisations and autism.

Only 70 percent of French people considered vaccines safe in a 2018 survey commissioned by the European Union executive. The EU average was 82 percent, but trust fell to 68 percent for the shot against seasonal flu.

The VCP project on vaccine trust, funded by the European Commission and pharmaceutical companies among others, aims to identify early signs and causes of public mistrust and tackle them with information campaigns before it is too late.

Larson said headlines referring to Warp Speed - the name of the US operation aimed at delivering a Covid-19 vaccine to the US population by next year - could increase vaccine hesitancy even more than perceptions that the disease could become less lethal.

"One of the most frequent things that comes up in people's conversations is concerns about how quick it is. If I have to pick one theme that is more recurrent than others it is this one," Larson said.

Data collected by VCP from social media show that by the end of June about 40 percent of Britons' posts concerning a Covid-19 vaccine, for example, were negative, with many distrusting any coronavirus vaccine and the medical establishment.

Announcements about fast progress in Covid vaccines in Russia and China in particular could also contribute to rising scepticism. "We don't have transparency and don't know how accurate or valid their data are," Ratzan said, adding that errors there could boost scepticism elsewhere.

Key for any information campaign to be successful is to tailor it to different audiences as there is no uniform profile of anti-vaxxers, said Kate Elder of Doctors Without Borders, a non-governmental organisation.

"They go from the highly educated to those who don't believe in science," she said, urging politicians to be more careful in their messages on vaccines and to better explain the reasons behind potentially fast results against Covid-19.

"We are exploring the idea of a chatbot that will speak in different languages," said Ratzan, adding it could be something similar to Smokey Bear, the US Forest Service's campaign to educate about preventing wildfires.

"Different parts of the world will require different strategies. We know we need to tailor it and to be specific," he said.

Risks are high if hesitancy is not addressed quickly.

During the 2009 swine flu pandemic, growing scepticism about the vaccine led to a failure of the vaccination campaign in France, where only 8 percent of the population got a shot against the virus which is estimated to have killed around 280,000 people across the world.

A study published in May in the Lancet by a group of French scientists warned of similar risks now in the country where vaccine hesitancy went up from 18 percent in mid-March when a lockdown was imposed on the French to 26 percent by the end of that month.

"Distrust is likely to become an issue when the vaccine will be made available," the scientists concluded.

covid-19 vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Installation of electronic fiscal devices at snail's pace
    Installation of electronic fiscal devices at snail's pace
  • Sadika Sarker Safa, daughter of missing Jatiyatabadi Chhatra Dal leader Md Sohel, sobs for her father at a human chain organised by ‘Mayer Daak’, an organisation of the relatives of the victims of enforced disappearance, at the National Press Club yesterday. Sohel was the vice president of Bangshal thana unit Chhatra Dal, when he was picked up from the capital’s Shahbagh in 2013 by men claiming to be from law enforcement agencies and has been missing since then. Photo: TBS
    Extrajudicial killings decline, rights issues still a concern in Bangladesh
  • Two-thirds of LPG sellers hold on to bulk importers to stay afloat in dollar crisis
    Two-thirds of LPG sellers hold on to bulk importers to stay afloat in dollar crisis

MOST VIEWED

  • Infographics: Mehedi Hasan Marof/TBS
    India's export embargo sends onion prices soaring to Tk220 per kg
  • Infographic: TBS
    Automatic fuel oil pricing from March in Bangladesh
  • Mushfiqur takes legal action against Ekattor TV over 'false report'
    Mushfiqur takes legal action against Ekattor TV over 'false report'
  • Mixed prices in Dhaka's beef market despite set rate
    Mixed prices in Dhaka's beef market despite set rate
  • Tuhin Bin Salam has been at the helm of the business since his father died in 2017. Photo: Nayem Ali
    60-year legacy: A chronicle of Salam Stamp Centre
  • Is the energy demand forecast for 2021-41 based on the wrong premise?
    Is the energy demand forecast for 2021-41 based on the wrong premise?

Related News

  • Bolsonaro home raided, phone seized in Brazil vaccine records probe
  • WHO provides 11 lakh bivalent vaccines to Bangladesh: Minister
  • Incepta Pharma abandons Covid vaccine plan
  • AstraZeneca, Moderna recipients to receive Pfizer vaccine to mix-and-match
  • Children aged 5-11 to get Covid jabs from 11 August

Features

US Veto: Israel's license to kill

US Veto: Israel's license to kill

2h | Panorama
In the last 30 years, Akter Hossain performed more than 5,000 magic shows all over the country, even in India. Photos: Noor-A-Alam

The fading enchantment of Dhaka's magic schools

2h | Panorama
Climate solutions are debatable, but science is inescapable

Climate solutions are debatable, but science is inescapable

2h | Panorama
Say hello to my little friend: Scarface turns 40

Say hello to my little friend: Scarface turns 40

15h | Features

More Videos from TBS

Cricket icon and ‘Tied Test’ hero Joe Solomon dies at 93

Cricket icon and ‘Tied Test’ hero Joe Solomon dies at 93

13h | TBS SPORTS
Onion prices skyrocketed due to India's export ban

Onion prices skyrocketed due to India's export ban

14h | TBS Today
Most capped footballers in professional football

Most capped footballers in professional football

16h | TBS SPORTS
How to overcome dollar crisis

How to overcome dollar crisis

16h | TBS Round Table
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]